GAP NARROWING BETWEEN FACIAL FILLERS

The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.